Almazov National Medical Research Centre, 197341 St. Petersburg, Russia.
Department of Pharmacognosy and Industrial Pharmacy, Faculty of Fundamental Medicine, Lomonosov Moscow State University, 119991 Moscow, Russia.
Int J Mol Sci. 2024 Sep 19;25(18):10086. doi: 10.3390/ijms251810086.
Histiocytoses are rare diseases characterised by infiltration of affected organs by myeloid cells with a monocyte or dendritic cell phenotype. Symptoms can range from self-resolving localised forms to multisystemic lesions requiring specific treatment. To demonstrate extremely rare cases of CD68-negative cardiac histiocytosis with expression of SARS-CoV-2 antigen in infiltrate cells. We demonstrated a case of Erdheim-Chester disease in a 67-year-old man with pericardial involvement and positive dynamics with vemurafenib treatment, an autopsy case of xanthogranulomatous myopericarditis in a 63-year-old man, surgical material of xanthogranulomatous constrictive pericarditis in a 57-year-old man, and an autopsy case of xanthogranulomatosis in a 1-month-old girl. In all cases, xanthogranuloma cells expressed CD163, many of them spike protein SARS-CoV-2, while CD68 expression was detected only in single cells. In this article, we demonstrated four cases of extremely rare CD68-negative cardiac xanthogranulomatosis in three adults and one child with expression of the spike protein SARS-CoV-2 in M2 macrophages. This potential indirect association between COVID-19 and the development of histiocytosis in these patients warrants further investigation. To substantiate this hypothesis, more extensive research is needed.
组织细胞增多症是一种罕见疾病,其特征是受影响的器官被具有单核细胞或树突状细胞表型的髓样细胞浸润。症状范围从自限性局部形式到需要特定治疗的多系统病变。为了证明浸润细胞中表达 SARS-CoV-2 抗原的 CD68 阴性心脏组织细胞增多症的极其罕见病例。我们展示了一名 67 岁男性的 Erdheim-Chester 病病例,该患者有心包受累,且接受 vemurafenib 治疗后具有阳性动态,一名 63 岁男性的黄色肉芽肿性心肌心包炎尸检病例,一名 57 岁男性的黄色肉芽肿性缩窄性心包炎手术材料,以及一名 1 个月大女孩的黄色肉芽肿病尸检病例。在所有病例中,黄色肉芽肿细胞表达 CD163,其中许多细胞表达 SARS-CoV-2 刺突蛋白,而仅在单个细胞中检测到 CD68 表达。在本文中,我们展示了三例成人和一例儿童的四种极为罕见的 CD68 阴性心脏黄色肉芽肿性组织细胞增多症,这些病例中的 M2 巨噬细胞表达 SARS-CoV-2 的刺突蛋白。这表明 COVID-19 与这些患者的组织细胞增多症发展之间存在潜在的间接关联,需要进一步研究。为了证实这一假设,需要进行更广泛的研究。